In the United States, 36% of human papillomavirus (HPV)–related cancers occur among men. HPV vaccination can substantially reduce the risk of HPV infection; however, the vast majority of men are unvaccinated. This study developed and validated transtheoretical model–based measures for HPV vaccination in young adult men.
Design.
Cross-sectional measurement development.
Setting.
Online survey of young adult men.
Subjects.
Three hundred twenty-nine mostly college-attending men, ages 18 to 26.
Measures.
Stage of change, decisional balance (pros/cons), and self-efficacy.
Analysis.
The sample was randomly split into halves for exploratory principal components analysis (PCA), followed by confirmatory factor analyses (CFA) to test measurement models. Multivariate analyses examined relationships between scales.
Results.
For decisional balance, PCA revealed two uncorrelated five-item factors (pros α = .78; cons α = .83). For the self-efficacy scale, PCA revealed a single-factor solution (α = .83). CFA confirmed that the two-factor uncorrelated model for decisional balance and a single-factor model for self-efficacy. Follow-up analyses of variance supported the theoretically predicted relationships between stage of change, pros, and self-efficacy.
Conclusion.
This study resulted in reliable and valid measures of pros and self-efficacy for HPV vaccination that can be used in future clinical research.
Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2007. Available at: http://www.cdc.gov/STD/stats07/other.htm#HPV. Accessed January 12, 2013.
2.
DunneEFSternbergMMarkowitzLE. Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States—National Health And Nutrition Examination Survey, 2003–2006: Opportunity to measure HPV vaccine impact?J Infect Dis.2011;204:562–565.
3.
NielsonCMFloresRHarrisRB. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev.2007;16:1107–1114.
4.
ThomasTLSnellS. Vaccinate boys with the HPV vaccine? Really?J Spec Pediatr Nurs.2013;18:165–169.
5.
SmithJSGilbertPAMelendyA. Age-specific prevalence of human papillomavirus infection in males: A global review. J Adolesc Health. 2011;48:540–552.
6.
Centers for Disease Control and Prevention. Human papillomavirus–associated cancers—United States, 2004–2008. MMWR Morb Mortal Wkly Rep.2012;61:258–261.
7.
ChaturvediAK. Beyond cervical cancer: Burden of other HPV-related cancers among men and women. J Adolesc Health. 2010;46:S20–S26.
8.
RyersonABPetersESCoughlinSS. Burden of potentially human papillomavirus–associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer. 2008;113:2901–2909.
JosephDAMillerJWWuX. Understanding the burden of human papillomavirus–associated anal cancers in the US. Cancer. 2008;113:2892–2900.
11.
ChessonHWEkwuemeDUSaraiyaM. The cost-effectiveness of male HPV vaccination in the United States. Vaccine. 2011;29:8443–8450.
12.
Centers for Disease Control and Prevention. Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep.2007;56(RR02):1–24.
13.
Centers for Disease Control and Prevention. Recommendation on the use of quadrivalent human papillomavirus vaccine in males: Advisory Committee On Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep.2011;60:1705–1708.
14.
Centers for Disease Control and Prevention. Noninfluenza vaccination coverage among adults—United States, 2011. MMWR Morb Mortal Wkly Rep.2013;62:66–72.
15.
Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13–17 years—United States, 2011. MMWR Morb Mortal Wkly Rep.2012;61:671–677.
16.
PartridgeJMHughesJPFengQ. Genital human papillomavirus infection in men: Incidence and risk factors in a cohort of university students. J Infect Dis.2007;196:1128–1136.
17.
AllenJDFantasiaHCFontenotH. College men's knowledge, attitudes, and beliefs about the human papillomavirus infection and vaccine. J Adolesc Health. 2009;45:535–537.
18.
NewmanPALogieCHDoukasNAsakuraK. HPV vaccine acceptability among men: A systematic review and meta-analysis. Sex Transm Infect. 2013;89:568–574.
19.
KrawczykALauEPerezS. How to inform: Comparing written and video education interventions to increase human papillomavirus knowledge and vaccination intentions in young adults. J Am Coll Health. 2012;60:316–322.
20.
GottvallMTydénTHöglundATLarssonM. Knowledge of human papillomavirus among high school students can be increased by an educational intervention. Int J STD AIDS. 2010;21:558–562.
21.
ReiterPLStubbsBPanozzoCA. HPV and HPV vaccine education intervention: Effects on parents, healthcare staff, and school staff. Cancer Epidemiol Biomarkers Prev.2011;20:2354–2361.
22.
LambertEC. College students' knowledge of human papillomavirus and effectiveness of a brief educational intervention. J Am Board Fam Pract. 2001;14:178–183.
23.
GerendMABarleyJ. Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis.2009;36:58–62.
24.
KimHW. Gender differences in knowledge and health beliefs related to behavioral intentions to prevent human papillomavirus infection. Asia Pac J Public Health. 2013;25:248–259.
25.
BonafideK. Enhancing Male HPV Vaccine Acceptance: The Role of Altruism and Awareness of Male Specific Health Benefits [thesis]. Available at: http://surface.syr.edu/psy_thesis/3. Accessed August 7, 2014.
26.
KatzMLKamJAKriegerJLRobertoAJ. Predicting human papillomavirus vaccine intentions of college-aged males: An examination of parents' and son's perceptions. J Am Coll Health. 2012;60:449–459.
27.
DiClementeCCProchaskaJOGibertiniM. Self-efficacy and the stages of self-change of smoking. Cogn Ther Res.1985;9:181–200.
28.
VelicerWFDiClementeCCProchaskaJOBrandenburgN. Decisional balance measure for assessing and predicting smoking status. J Pers Soc Psychol. 1985;48:1279–1289.
29.
DiClementeCCProchaskaJOFairhurstSK. The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991;59:295–304.
30.
ProchaskaJODiClementeCC. Stages and processes of self-change of smoking: Toward an integrative model of change. J Consult Clin Psychol. 1983;51:390–395.
31.
ProchaskaJOVelicerWFRossiJS. Multiple risk expert systems interventions: Impact of simultaneous stage-matched expert system interventions for smoking, high-fat diet, and sun exposure in a population of parents. Health Psychol. 2004;23:503–516.
32.
LevesqueDACumminsCOProchaskaJMProchaskaJO. Randomized trial of stage-based interventions for informed Medicare choices. Health Care Financ Rev.2006;27:25–40.
33.
ProchaskaJOButterworthSReddingCA. Initial efficacy of MI, TTM tailoring and HRI's with multiple behaviors for employee health promotion. Prev Med.2008;46:226–231.
34.
JohnsonSSPaivaALCumminsCO. Transtheoretical model-based multiple behavior intervention for weight management: Effectiveness on a population basis. Prev Med.2008;46:238–246.
35.
Di NoiaJContentoIRProchaskaJO. Computer-mediated intervention tailored on transtheoretical model stages and processes of change increases fruit and vegetable consumption among urban African-American adolescents. Am J Health Promot. 2008;22:336–341.
36.
PaivaALLipschitzJMFernandezAC. Evaluation of the acceptability and feasibility of a computer-tailored intervention to increase HPV vaccination among young adult women. J Am Coll Health. 2014;62:32–38.
37.
HallKLRossiJS. Meta-analytic examination of the strong and weak principles across 48 health behaviors. Prev Med.2008;46:266–274.
38.
BanduraA. Self-efficacy mechanism in human agency. Am Psychol. 1982;37:122–147.
39.
BanduraA. Self-efficacy: Toward a unifying theory of behavioral change. Psychol Rev.1977;84:191–215.
40.
VelicerWFDiClementeCCRossiJSProchaskaJO. Relapse situations and self-efficacy: An integrative model. Addict Behav. 1990;15:271–283.
41.
RossiJSReddingCA. Structure and function of self-efficacy across the stages of change for ten health behaviors. Ann Behav Med.2001;23(suppl):S94.
42.
BrugJConnerMHarreN. The transtheoretical model and stages of change: A critique: Observations by five commentators on the paper by Adams, J. and White, M. (2004) why don't stage-based activity promotion interventions work?Health Educ Res.2005;20:244–258.
43.
WestR. Time for a change: Putting the transtheoretical (stages of change) model to rest. Addiction. 2005;100:1036–1039.
44.
NoarSMBenacCNHarrisMS. Does tailoring matter? meta-analytic review of tailored print health behavior change interventions. Psychol Bull.2007;133:673–693.
45.
ProchaskaJODiClementeCC. Transtheoretical therapy: Toward a more integrative model of change. Psychother Theory Res Pract. 1982;19:276–288.
46.
JanisILMannL. Decision Making: A Psychological Analysis of Conflict, Choice, and Commitment. London, UK: Cassel & Collier Macmillan; 1977.
47.
BanduraA. Self-Efficacy: The Exercise of Control. New York, NY: WH Freeman/Times Books/Henry Holt & Co; 1997:ix.
48.
LipschitzJMFernandezACLarsonHE. Validation of decisional balance and self-efficacy measures for HPV vaccination in college women. Am J Health Promot. 2013;27:299–307.
49.
JacksonDN. The dynamics of structured personality tests. Psychol Rev.1971;78:229–248.
50.
JacksonDN. A sequential system for personality scale development. In: SpeilbergerCD, ed. Current Topics in Clinical and Community Psychology. Vol 2. New York, NY: Academic Press; 1970:61–96.
51.
ReddingCAMaddockJERossiJS. The sequential approach to measurement of health behavior constructs: Issues in selecting and developing measures. Californian J Health Promot. 2006;4:83–101.
NoarSM. The role of structural equation modeling in scale development. Struct Equation Model. 2003;10:622–647.
54.
GuadagnoliEVelicerWF. Relation of sample size to the stability of component patterns. Psychol Bull.1988;103:265–275.
55.
VelicerWF. The relation between factor score estimates, image scores, and principal component scores. Educ Psychol Meas. 1976;36:149–159.
56.
HornJL. A rationale and test for the number of factors in factor analysis. Psychometrika. 1965;30:179–185.
57.
BentlerPM. EQS: Structural Equation Modeling Program Manual. Los Angeles, Calif: BMNP; 1993.
58.
HuLBentlerPM. Evaluating model fit. In: HoyleR, ed. Structural Equation Modeling. Thousand Oaks, Calif: Sage; 1995:76–99.
59.
KlineRB. Principles and Practice of Structural Equation Modeling. 2nd ed.New York, NY: Guilford Press; 2005.
60.
ProchaskaJOVelicerWFRossiJS. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13:39–46.
61.
LiauAStupianskyNWRosenthalSLZimetGD. Health beliefs and vaccine costs regarding human papillomavirus (HPV) vaccination among a US national sample of adult women. Prev Med.2012;54:277–279.
62.
AmoyalNRRobbinsMPaivaABurdittCKesslerDShazB. Measuring the processes of change for increasing blood donation in black adults. Transfusion. 2012;53:1280–1290.
63.
SternbergPHubleyJ. Evaluating men's involvement as a strategy in sexual and reproductive health promotion. Health Promot Int.2004;19:389–396.
64.
CollumbienMHawkesS. Missing men's messages: Does the reproductive health approach respond to men's sexual health needs?Cult Health Sex. 2000;2:135–150.
